TP53 and melanoma: The in vivo performance of our gene transfer approach corroborates with previous work (20, 22, 52), but nevertheless, it is unprecedented since this is the first demonstration of the use of a p53-responsive adenoviral vector for the transfer of p14ARF+IFNβ to human melanoma cells.